I don’t see the need for the ?, but that’s just me
Trump Vindicated? New Peer-Reviewed Hydroxychloroquine Study Shows Reduced COVID-19 Mortality.
A new large-scale study conducted by the Henry Ford Health System concluded that hydroxychloroquine, the anti-malaria drug touted by Trump as a potentially game-changing treatment for the coronavirus, successfully lowered mortality rates for hospitalized coronavirus patients. The results were published Thursday in the peer-reviewed International Journal of Infectious Diseases.
Just The News reported on its findings:
The study examined 2,541 patients who had been hospitalized in six hospitals between March 10 and May 2, 2020.
More than twenty-six percent (26.4%) of patients who did not receive hydroxychloroquine died.
But among those who received hydroxychloroquine, fewer than half that number — 13% — died.
More than 90% of the patients received hydroxychloroquine within 48 hours of admission to the hospital. Scientists say giving the drug early during illness may be a key to success.


